FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

422002006: Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3682825015 Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682827011 Rosiglitazone maleate 2 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4707781000005111 rosiglitazon 2 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    rosiglitazon 2 mg tablet Is a Product containing rosiglitazone (medicinal product) false Inferred relationship Some
    rosiglitazon 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Oralt blodsukkersænkende middel false Inferred relationship Some
    rosiglitazon 2 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    rosiglitazon 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone (substance) false Inferred relationship Some
    rosiglitazon 2 mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    rosiglitazon 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate false Inferred relationship Some
    rosiglitazon 2 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    rosiglitazon 2 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate false Inferred relationship Some 1
    rosiglitazon 2 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rosiglitazone maleate false Inferred relationship Some 1
    rosiglitazon 2 mg tablet Has presentation strength numerator value to false Inferred relationship Some 1
    rosiglitazon 2 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
    rosiglitazon 2 mg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    rosiglitazon 2 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    rosiglitazon 2 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rosiglitazone maleate false Inferred relationship Some 1
    rosiglitazon 2 mg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    rosiglitazon 2 mg tablet Is a Product containing rosiglitazone in oral dose form (medicinal product form) false Inferred relationship Some
    rosiglitazon 2 mg tablet Count of base of active ingredient en false Inferred relationship Some
    rosiglitazon 2 mg tablet Is a Rosiglitazone only product in oral dose form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start